PUBLISHER: Grand View Research | PRODUCT CODE: 2040799
PUBLISHER: Grand View Research | PRODUCT CODE: 2040799
The global non-silver antimicrobial wound dressing market size was estimated at USD 529.41 million in 2025 and is projected to reach USD 739.11 million by 2033, growing at a CAGR of 4.35% from 2026 to 2033. The non-silver antimicrobial wound dressing industry is driven by the rising prevalence of chronic wounds and the increasing number of surgical procedures requiring effective infection control.
Concerns over antimicrobial resistance and the cytotoxicity of silver-based products are accelerating the shift toward alternatives like iodine, honey, and PHMB. Growing awareness of advanced wound care and an aging population further support market growth.
The rising prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, is significantly driving demand for non-silver antimicrobial wound dressings. These wounds require long-term management and effective infection control, which increases the use of safer, less cytotoxic alternatives such as PHMB and iodine-based dressings. As the patient pool continues to grow, the need for advanced, sustainable wound care solutions is accelerating market growth.
Furthermore, the increasing incidence of venous leg ulcers is driving the demand for non-silver antimicrobial wound dressings, as these wounds require prolonged treatment and consistent infection control. Non-silver options such as PHMB and iodine-based dressings are preferred for their safety, reduced cytotoxicity, and suitability for long-term use. As the burden of venous ulcers rises, the need for effective, patient-friendly wound care solutions continues to drive market growth.
The increasing number of surgical procedures and traumatic injuries is driving demand for non-silver antimicrobial wound dressings, as effective infection prevention is critical for post-operative and acute wound care. These dressings offer safer alternatives with lower cytotoxicity, making them suitable for repeated use during recovery. As surgical volumes and injury cases rise, the need for reliable and advanced wound management solutions continues to grow.
Technological advancements in wound care materials are driving the non-silver antimicrobial wound dressing industry by enabling the development of more effective, biocompatible, and targeted antimicrobial solutions such as PHMB and iodine-based formulations. These innovations enhance healing outcomes, reduce infection risks, and support wider adoption across both clinical and home care settings.
As a result, the growing burden of chronic wounds, including diabetic foot ulcers, pressure ulcers, and venous leg ulcers, along with rising surgical and trauma cases and continuous advancements in wound care materials, is collectively driving the demand for non-silver antimicrobial wound dressings. In addition, the increasing preference for safer, low-cytotoxic alternatives and the need for effective long-term wound management solutions are further supporting sustained market growth.
Global Non-silver Antimicrobial Wound Dressing Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global non-silver antimicrobial wound dressing market report based on the product, application, end-use, and region: